New analysis from Avalere Health finds that some exchange plans place all drugs used to treat complex diseases - such as HIV, cancer, and multiple sclerosis - on the highest drug formulary cost-sharing tier.
28 States & DC Are Expanding Medicaid Eligibility; Others May Decide to Expand
In 2014 the healthcare industry saw fundamental change in how health plans approach the market, provider consolidation in many areas, a focus on quality-based payments, unprecedented growth in consumer liability for the cost of chronic illness, and a slowing in the rise in healthcare costs.
Today, the President released his Budget for the 2016 Fiscal Year. Avalere Health offers the following observations.
Avalere released its latest white paper on patient-reported outcomes (PROs) today in collaboration with leaders from patient, payer, health information technology, product development and research communities.
On Monday, January 26, Secretary Burwell announced a goal to have half of Medicare fee-for-service payment in alternative payment models (APMs) by 2018.
The House Energy and Commerce Committee released a legislative discussion draft yesterday as part of its 21st Century Cures initiative.
Avalere published an article this week on ASCO's plan to launch CancerLinQ™.
With less than a month to go in 2015 exchange open enrollment, the Department of Health and Human Services (HHS) today released new estimates of sign-ups to date. But where do we really stand?
Avalere Health & The Alliance for Home Health Quality & Innovation released a Chartbook as an overview of home health patients, workforce, organizational trends, and economic contributions.
Determining the cost or co-payment of a specialty drug-high-cost drugs typically used to treat complex diseases like cancer or rheumatoid arthritis-has always been complicated.
On Tuesday, December 23, the Measure Applications Partnership (MAP) released draft recommendations for inclusion of measures in federal programs.
The Avalere Center for Payment & Delivery Innovation is a leading voice in helping organizations succeed in a value-based healthcare environment.
Despite its notable negative impact on patient outcomes and costs of care, malnutrition is an area that has largely remained unaddressed by national programs and initiatives.
PuttingPatientsFirst.net uses Avalere Analytics to Educate Patients about Exchange Choices
A new analysis by Avalere Health estimates that exchange enrollment will total 10.5 million people by the end of 2015, though enrollment could fluctuate up or down by approximately 1 million individuals.
New analysis from Avalere Health finds that 74 percent of Silver plans offered on exchanges have maximum out-of-pocket limits below what is required by law.
FDA passed the Final Rule for Unique Device Identification (UDI) on September 24, 2013 with the rollout of Class III devices one year later.
In 2015, Avalere Health and the Center for Medical Technology Policy will work together to develop the Partnership for Enhanced Recovery to promote broader adoption of proven protocols in the surgical space across a number of US hospitals.
A new analysis from Avalere Health finds that patients accessing specialty medications - drugs often used to treat life threatening illnesses, such as cancer, rheumatoid arthritis, or multiple sclerosis - through exchange plans are more likely to experience higher out-of-pocket costs in 2015 than in 2014.
